Cisplatin cardiomyopathy
WebJun 1, 2013 · Cisplatin-based combinations are standard regimens in the treatment of advanced non-small cell lung cancer, significantly improving survival of patients. … WebNational Center for Biotechnology Information
Cisplatin cardiomyopathy
Did you know?
WebMar 12, 2015 · We previously demonstrated that the increase in troponin I (TnI) soon after high-dose chemotherapy (HDC) is a strong predictor of left ventricular dysfunction and poor cardiac outcome, particularly in patients showing a persistent TnI increase. 5,6 This finding has important clinical implications and allows the identification of patients at high risk of … WebMar 17, 2024 · Cardiotoxicity is defined as any heart injury (functional or structural) related to cancer treatment, taking into consideration chemotherapy, radiotherapy …
WebJul 27, 2024 · Conventional doxorubicin: Treatment (in combination regimens with cisplatin, methotrexate, and vinblastine) of invasive and advanced bladder carcinoma. ... Pediatric patients are at increased risk for developing delayed cardiotoxicity; doxorubicin-induced cardiomyopathy impairs myocardial growth as pediatric patients mature, … WebWARNING: CARDIOMYOPATHY, INFUSION REACTIONS, EMBRYO-FETAL TOXICITY, and PULMONARY TOXICITY See full prescribing information for complete boxed warning Cardiomyopathy: trastuzumab products can result in subclinical and clinical cardiac ... Cisplatin was administered at 80 mg/m on Day 1 and the
WebCytostatic antibiotics of the anthracycline class are the best known of the chemotherapeutic agents that cause cardiotoxicity. Alkylating agents such as cyclophosphamide, ifosfamide, cisplatin, carmustine, busulfan, chlormethine and mitomycin have also been associated with cardiotoxicity. WebCisplatin-induced cardiotoxicity is a well describe effect with a low incidence. Supraventricular arrhythmias and coro-nary artery disease are the main cardiac effects. ... Cardiotoxicity secondary to cisplatin administration manifests as both delayed effects (mainly as chronic ischemic cardiomyopathy and arterial hypertension) and acute ...
WebJan 1, 2013 · Patients receiving cisplatin-based chemotherapy may experience coronary artery diseases, arrhythmias, and cardiomyopathy 3). Moore et al. have reported cases of arterial thrombosis with subsequent ...
WebApr 11, 2024 · Cisplatin is a widely used chemotherapeutic agent for treatment of various cancers. However, treatment with cisplatin is associated with drug resistance and several adverse side effects such as nephrotoxicity, reduced immunity towards infections and … ohvi and peacehealthWebNational Center for Biotechnology Information ohv license californiaWebJun 1, 2024 · Cisplatin (CP)-induced nephrotoxicity is widely accepted as a model for acute kidney injury (AKI). ... We showed that old mice had more severe kidney injury and cardiomyopathy after exposure to ... ohv registration renewalWebFeb 2, 2024 · Learn about the potential side effects of pemetrexed. Includes common and rare side effects information for consumers and healthcare professionals. ohv off road ridingWebJan 10, 2011 · Combinations of cisplatin with other anticancer drugs as methotrexate, 5-fluorouracil, bleomycin and doxorubicin are associated with lethal cardiomyopathy ( … ohv pastoral companyWebCisplatin can induce direct myocardial toxicity leading to atrial fibrillation whereas the potential of myocardial toxicity is amplified when the drug is administered in … myinfinity alexaWebNov 17, 2024 · joint or muscle pain. loss of appetite. lower back or side pain. muscle tremors. nausea or vomiting. rapid, deep breathing. red, irritated eyes. red skin lesions, often with a purple center. restlessness. oh voter registration lookup